Job stress and its impact on daytime sleepiness among nurses in Palestine: a cross-sectional study
Abstract
Excessive daytime sleepiness (EDS) is a growing public health concern particularly concerning healthcare workers like nurses due to demanding schedules. Job stress significantly contributes to health issues, including sleep disturbance, and its relationship with EDS in nurses has implications for patient care. This study examined the prevalence of EDS and its association with job stress among Palestinian nurses. A quantitative cross-sectional design was used with the Arabic versions of the Epworth Sleepiness Scale (ESS) and Nursing Stress Scale (NSS). A convenience sample of 392 nurses from 16 Palestinian hospitals in the North West Bank was recruited, with 345 valid responses (88% response rate). Data were collected via a self-report questionnaire and analyzed via descriptive and inferential statistics. Pearson correlation assessed the relationship between job stress and EDS. Multiple linear regression identified significant predictors. A weak but statistically significant positive correlation (r = 0.126, p = 0.019) was found between job stress and EDS, suggesting a modest effect size. Notably, the prevalence of EDS was high (37.7%). The most reported stressors were workload (AM = 1.39) and exposure to death and dying (AM = 1.19). Lower work experience and not engaging in stress-relieving activities predicted EDS, while gender, academic level, and hospital type predicted job stress. Although the correlation was weak, its clinical relevance lies in the cumulative impact of…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.